Letermovir
CAS: 917389-32-3
Ref. TM-T5396
1mg | 87.00 € | ||
2mg | 115.00 € | ||
5mg | 205.00 € | ||
10mg | 276.00 € | ||
25mg | 488.00 € | ||
50mg | 708.00 € | ||
100mg | 994.00 € | ||
500mg | 1,984.00 € | ||
1mL*10mM (DMSO) | 253.00 € |
Product Information
- MK-8828
- AIC246
- (4S)-8-Fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetic acid
- (S)-2-(8-Fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid
- 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-
- Aic 246
- Prevymis
Letermovir (AIC246) (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.
Chemical properties
Technical inquiry about: TM-T5396 Letermovir
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.